D. E. Shaw & Co., Inc. West Pharmaceutical Services Inc Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 284,336 shares of WST stock, worth $79.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

284,336

Previous 103,022 176.0%

Holding current value

$79.4 Million

Previous $23.1 Million 169.74%

% of portfolio

0.05%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$190.39 - $227.7 $34.5 Million - $41.3 Million	181,314 Added 176.0%	284,336 $62.2 Million
Q1 2025 May 15, 2025	SELL	$199.11 - $347.87 $64.3 Million - $112 Million	-322,893 Reduced 75.81%	103,022 $23.1 Million
Q4 2024 Feb 14, 2025	BUY	$285.69 - $344.0 $119 Million - $144 Million	417,995 Added 5277.71%	425,915 $140 Million
Q3 2024 Nov 14, 2024	SELL	$277.16 - $333.3 $2.03 Million - $2.44 Million	-7,322 Reduced 48.04%	7,920 $2.38 Million
Q2 2024 Aug 14, 2024	SELL	$314.68 - $395.94 $3.02 Million - $3.8 Million	-9,604 Reduced 38.65%	15,242 $5.02 Million
Q1 2024 May 15, 2024	SELL	$338.27 - $413.0 $1.42 Million - $1.73 Million	-4,198 Reduced 14.45%	24,846 $9.83 Million
Q4 2023 Feb 14, 2024	BUY	$318.29 - $392.21 $9.24 Million - $11.4 Million	29,044 New	29,044 $10.2 Million
Q2 2023 Aug 14, 2023	BUY	$334.63 - $382.47 $2.47 Million - $2.82 Million	7,370 Added 653.37%	8,498 $3.25 Million
Q1 2023 May 15, 2023	SELL	$232.5 - $346.47 $2.52 Million - $3.76 Million	-10,843 Reduced 90.58%	1,128 $390,000
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $9.24 Million - $11.6 Million	-44,155 Reduced 78.67%	11,971 $2.82 Million
Q3 2022 Nov 14, 2022	SELL	$246.08 - $343.65 $6.86 Million - $9.58 Million	-27,887 Reduced 33.19%	56,126 $13.8 Million
Q2 2022 Aug 15, 2022	BUY	$280.61 - $420.45 $23.2 Million - $34.8 Million	82,789 Added 6763.81%	84,013 $25.4 Million
Q1 2022 May 16, 2022	BUY	$357.49 - $445.92 $204,126 - $254,620	571 Added 87.44%	1,224 $503,000
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $262,669 - $307,785	653 New	653 $306,000
Q1 2021 May 17, 2021	SELL	$257.29 - $307.53 $261,406 - $312,450	-1,016 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$261.16 - $301.66 $235,044 - $271,494	-900 Reduced 46.97%	1,016 $288,000
Q3 2020 Nov 16, 2020	SELL	$224.99 - $288.02 $549,200 - $703,056	-2,441 Reduced 56.02%	1,916 $527,000
Q2 2020 Aug 14, 2020	SELL	$149.8 - $227.17 $1.24 Million - $1.87 Million	-8,250 Reduced 65.44%	4,357 $990,000
Q1 2020 May 15, 2020	SELL	$128.96 - $174.76 $1.79 Million - $2.42 Million	-13,848 Reduced 52.35%	12,607 $1.92 Million
Q4 2019 Feb 14, 2020	SELL	$137.6 - $151.21 $5.84 Million - $6.41 Million	-42,414 Reduced 61.59%	26,455 $3.98 Million
Q3 2019 Nov 14, 2019	BUY	$121.41 - $150.02 $2.77 Million - $3.42 Million	22,789 Added 49.46%	68,869 $9.77 Million
Q2 2019 Aug 14, 2019	SELL	$111.27 - $125.15 $411,476 - $462,804	-3,698 Reduced 7.43%	46,080 $5.77 Million
Q1 2019 May 15, 2019	BUY	$94.53 - $110.2 $4.71 Million - $5.49 Million	49,778 New	49,778 $5.49 Million
Q4 2018 Feb 14, 2019	SELL	$93.0 - $123.98 $565,812 - $754,294	-6,084 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$98.01 - $123.47 $301,086 - $379,299	-3,072 Reduced 33.55%	6,084 $751,000
Q2 2018 Aug 14, 2018	SELL	$83.32 - $101.88 $608,819 - $744,437	-7,307 Reduced 44.38%	9,156 $909,000
Q1 2018 May 15, 2018	SELL	$85.56 - $102.4 $655,988 - $785,100	-7,667 Reduced 31.77%	16,463 $1.45 Million
Q4 2017 Feb 14, 2018	BUY	$91.65 - $101.65 $173,585 - $192,525	1,894 Added 8.52%	24,130 $2.38 Million
Q3 2017 Nov 14, 2017	BUY	$84.54 - $96.75 $1.88 Million - $2.15 Million	22,236	22,236 $2.14 Million

Others Institutions Holding WST

# of Institutions

829

Shares Held

68.6M

Call Options Held

344K

Put Options Held

144K

View Full List

About WEST PHARMACEUTICAL SERVICES INC

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $20.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

More about WST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account